|
1
|
Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion.
|
Mol Cancer Res
|
2008
|
1.18
|
|
2
|
Expression of toll-like receptor-9 is increased in poorly differentiated prostate tumors.
|
Prostate
|
2010
|
1.08
|
|
3
|
Expression of macrophage inhibitory cytokine-1 in prostate cancer bone metastases induces osteoclast activation and weight loss.
|
Prostate
|
2009
|
1.06
|
|
4
|
Toll-like receptor 9 is a novel biomarker for esophageal squamous cell dysplasia and squamous cell carcinoma progression.
|
J Innate Immun
|
2011
|
1.06
|
|
5
|
Toll-like receptor-9 expression is inversely correlated with estrogen receptor status in breast cancer.
|
J Innate Immun
|
2008
|
0.98
|
|
6
|
Low TLR9 expression defines an aggressive subtype of triple-negative breast cancer.
|
Breast Cancer Res Treat
|
2012
|
0.98
|
|
7
|
Absent Toll-like receptor-9 expression predicts poor prognosis in renal cell carcinoma.
|
J Exp Clin Cancer Res
|
2011
|
0.98
|
|
8
|
Expression of Toll-like receptor-9 is associated with poor progression-free survival in prostate cancer.
|
Oncol Lett
|
2013
|
0.86
|